Orange Book product · Brand (NDA)
ERIVEDGE
VISMODEGIB
Brand (NDA)NDA 203388RX GENENTECH
At a glance
Jan 30, 2012
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 30, 2012
14 yr 7 mo ago
Today
Patent 7888364 expires
Listed drug substance patent expiration.
Nov 11, 2028
in 2 yr 5 mo
Patent 9278961 expires
Listed method-of-use patent (U-1825) expiration.
Dec 15, 2028
in 2 yr 6 mo
Pharmaceutical detail
Active ingredient
VISMODEGIB
Strength
150MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 203388
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7888364 | Nov 11, 2028 | in 2 yr 5 mo | SubstanceProduct |
| 9278961 | Dec 15, 2028 | in 2 yr 6 mo | U-1825 |
